Biotech startups are using generative AI for everything from protein creation to DNA sequencing.ChatGPT has kickstarted a frenzy around generative AI.
"Drug discovery, antibody discovery, and protein discovery are all fantastic applications of the tech," he added. As seen in the case of AI drug discovery startups, scientists have been able to take large-scale datasets to better predict trial outcomes, and recognize subjective bias when identifying targets.
A key benefit of this, he added, is that AI takes data and information and turns it into insights — which can speed up the development of drugs and medicine, so the product can be brought to market quicker.The sector is in the early stages of applying generative technology — but founders are becoming aware of its limitations.